MS Multiple Sclerosis
Conditions
Interventions
None listed
Sponsors
Universiteit Maastricht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Relapsing-remitting MS patients between 20-40 years female use of exclusively interferon beta (> 2 months)
Exclusion criteria
Exclusion criteria: use of immune modulatory drugs other then interferon beta
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The VDR expression levels will be determined both on the protein and mRNA level. VDR protein and mRNA levels will be measured in different MS-associated T cell subsets. | — |
Secondary
| Measure | Time frame |
|---|---|
| Next, VDR expression levels will be compared between RRMS patients and healthy volunteers. | — |
Countries
Netherlands
Outcome results
None listed